67 related articles for article (PubMed ID: 8140329)
21. Antimicrobial susceptibility and pulsed-field gel electrophoresis of Shigella sonnei strains in Malaysia (1997-2000).
Hoe CH; Yasin RM; Koh YT; Thong KL
J Appl Microbiol; 2005; 99(1):133-40. PubMed ID: 15960673
[TBL] [Abstract][Full Text] [Related]
22. Effect of opsonophagocytosis mediated by specific antibodies on the co-amoxiclav serum bactericidal activity against Streptococcus pneumoniae after administration of a single oral dose of pharmacokinetically enhanced 2000/125 mg co-amoxiclav to healthy volunteers.
Alou L; Aguilar L; Sevillano D; Giménez MJ; Laguna B; Echeverría O; Carcas A; Lubomirov R; Casal J; Prieto J
J Antimicrob Chemother; 2005 May; 55(5):742-7. PubMed ID: 15761068
[TBL] [Abstract][Full Text] [Related]
23. Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type beta-lactamase.
Kang CI; Pai H; Kim SH; Kim HB; Kim EC; Oh MD; Choe KW
J Antimicrob Chemother; 2004 Dec; 54(6):1130-3. PubMed ID: 15486080
[TBL] [Abstract][Full Text] [Related]
24. Use of a water-based probiotic to treat common gut pathogens.
Dodoo CC; Stapleton P; Basit AW; Gaisford S
Int J Pharm; 2019 Feb; 556():136-141. PubMed ID: 30543889
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
Koksal F; Ak K; Kucukbasmaci O; Samasti M
Chemotherapy; 2009; 55(4):293-7. PubMed ID: 19521075
[TBL] [Abstract][Full Text] [Related]
26. Enteric gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit.
Cordero L; Rau R; Taylor D; Ayers LW
Am J Infect Control; 2004 Jun; 32(4):189-95. PubMed ID: 15175611
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial activity of extracts of local cough mixtures on upper respiratory tract bacterial pathogens.
Adeleye IA; Opiah L
West Indian Med J; 2003 Sep; 52(3):188-90. PubMed ID: 14649097
[TBL] [Abstract][Full Text] [Related]
28. In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae.
Burgess DS; Hall RG
Diagn Microbiol Infect Dis; 2004 May; 49(1):41-6. PubMed ID: 15135499
[TBL] [Abstract][Full Text] [Related]
29. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
30. Epidemiological and antibiotic resistant study on extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Zhejiang Province.
Yu Y; Zhou W; Chen Y; Ding Y; Ma Y
Chin Med J (Engl); 2002 Oct; 115(10):1479-82. PubMed ID: 12490091
[TBL] [Abstract][Full Text] [Related]
31. Sensitivity of Shigella strains to bactericidal activity of human serum. I. Participation of two independently active mechanisms in bactericidal action against Shigella sonnei phase II.
Mokracka-Latajka G; Grzybek-Hryncewicz K; Jankowski S
Acta Microbiol Pol; 1990; 39(3-4):111-6. PubMed ID: 1715644
[TBL] [Abstract][Full Text] [Related]
32. Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems using an in vitro model.
Zhanel GG; Baudry PJ; Tailor F; Cox L; Hoban DJ; Karlowsky JA
J Antimicrob Chemother; 2009 Oct; 64(4):824-8. PubMed ID: 19643776
[TBL] [Abstract][Full Text] [Related]
33. In vitro susceptibilities of Escherichia coli and Klebsiella spp. to ampicillin-sulbactam and amoxicillin-clavulanic acid.
Kacmaz B; Sultan N
Jpn J Infect Dis; 2007 Jul; 60(4):227-9. PubMed ID: 17642541
[TBL] [Abstract][Full Text] [Related]
34. New thioureides of 2-(4-methylphenoxymethyl) benzoic acid with antimicrobial activity.
Drăcea O; Larion C; Chifiriuc MC; Raut I; Limban C; Niţulescu GM; Bădiceanu CD; Israil AM
Roum Arch Microbiol Immunol; 2008; 67(3-4):92-7. PubMed ID: 19496477
[TBL] [Abstract][Full Text] [Related]
35. Comparison of faecal and optimal growth conditions on in vitro pharmacodynamic activity of marbofloxacin against Escherichia coli.
Pellet T; Gicquel-Bruneau M; Sanders P; Laurentie M
Res Vet Sci; 2006 Jun; 80(3):324-35. PubMed ID: 16126240
[TBL] [Abstract][Full Text] [Related]
36. Bacterial antagonists of Shigellae.
Pokorný J
J Hyg Epidemiol Microbiol Immunol; 1986; 30(2):199-205. PubMed ID: 3522730
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial activity of epsilon-polylysine against Escherichia coli O157:H7, Salmonella Typhimurium, and Listeria monocytogenes in various food extracts.
Geornaras I; Yoon Y; Belk KE; Smith GC; Sofos JN
J Food Sci; 2007 Oct; 72(8):M330-4. PubMed ID: 17995614
[TBL] [Abstract][Full Text] [Related]
39. Secretory immunoglobulin A obtained from pooled human colostrum and milk for oral passive immunization.
Carbonare CB; Carbonare SB; Carneiro-Sampaio MM
Pediatr Allergy Immunol; 2005 Nov; 16(7):574-81. PubMed ID: 16238582
[TBL] [Abstract][Full Text] [Related]
40. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
Duttaroy B; Mehta S
Indian J Pathol Microbiol; 2005 Jan; 48(1):45-8. PubMed ID: 16758790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
